Discuss treatment and driving safety
Bring driving into your treatment review, looking at both attention problems and possible side effects.
Very low certaintyADHD evidence
Start with the time you have
1 minute
Write down one driving moment that worried you, to take to your clinician.
5 minutes
Write down attention problems or side effects that could affect your driving.
15 minutes
Write a question about driving for your treatment review, and find the official local reporting guidance.
A plan
Include driving in the clinical review
- Describe driving-related difficulties and treatment effects.
- Ask the clinician about fitness to drive in your situation.
- Follow the agreed safety plan and local licensing requirements.
How sure the science is
Very low certainty, ADHD evidence
We barely know. Small or short trials, and people knew what they were getting. The true effect could be much smaller, or zero. Measured in people with ADHD.
- 3 trials
- 154 people
- adults
- clinician rated
- about 12 weeks
- measured on driving
NICE NG87 1.4.3 recommends discussing driving; EBI driving trials very low certainty; registry associations non-randomised. See this row on the evidence map
The number, drawn
Ask your clinician if you are unsure whether driving on treatment is safe
Why it matters
ADHD is associated with higher transport risk, and a large registry study linked medication treatment with fewer transport accidents (adjusted rate ratio 0.88), though that does not prove cause. In EBI, small adult methylphenidate trials gave an uncertain driving result, SMD 0.53 with a confidence interval from -0.073 to 1.133 and very low certainty, over about 12 weeks or to trial endpoint. NICE recommends talking about driving after diagnosis, and NHS guidance notes that dizziness, sleepiness or sight problems from medicine can make driving unsafe.
How to do it
- Tell your prescriber whether you drive, and describe any attention worries or near misses.
- Report sleepiness, dizziness, changes in vision or any other treatment effect that matters behind the wheel.
- Ask how your symptoms and treatment affect your fitness to drive, in your circumstances.
- Check the local licensing and reporting rules with an official source.
Do not drive if symptoms or side effects make it unsafe. Medication does not guarantee safe driving, so get individual clinical advice and follow local licensing rules.
Putting it into practice
In real life
- Mention a near miss at your review rather than discussing concentration only in the office.
- Ask whether dizziness or sleepiness could affect how safely you drive.
Watch out for
- Common mistakeA registry link cannot certify that you personally are safe to drive. Ask for an assessment of you.
- Common mistakeIf you only look for symptom benefit, you can miss medicine effects that make driving worse. Report both.
Trusted guides
How we rated it
- Evidence grade
- A Moderate or high certainty evidence in people with ADHD, or an explicit ADHD guideline recommendation.
- The number
- Ask your clinician if you are unsure whether driving on treatment is safe (NHS, 2025)
- Benefit
- 55/100 The benefit score is an editorial prioritization for the general list, weighted by certainty. It is not a prediction of what will happen for you.
- Effort
- Quick win
Sources
- Tier 1 guidelineCommon questions about methylphenidate for adultsNHS, 2025
- Tier 1 guidelineEBI-ADHD: companion data to Gosling et al., BMJ 2025, commit 86eff22a9ffbBMJ / Gosling et al., 2025
- Tier 1 guidelineBenefits and harms of ADHD interventions: umbrella review and platform for shared decision makingBMJ, 2025
- Tier 2 studyADHD drug treatment and risk of suicidal behaviours, substance misuse, accidental injuries, transport accidents, and criminality: emulation of target trialsBMJ, 2025
- Tier 1 guidelineAttention deficit hyperactivity disorder: diagnosis and management (NG87), recommendationsNICE, 2019
General information about ADHD, not a diagnosis or an individual treatment plan. Tailoring changes the order of suggestions; it does not assess you. Medication decisions belong with you and a qualified clinician.